Volume 14, Issue 1, Pages (July 2008)

Slides:



Advertisements
Similar presentations
Volume 21, Issue 1, Pages (January 2012)
Advertisements

Illuminating the Properties of Prostate Luminal Progenitors
Volume 15, Issue 1, Pages (July 2014)
Building better therapy for children with acute lymphoblastic leukemia
Volume 14, Issue 1, Pages (January 2014)
Volume 6, Issue 4, Pages (April 2010)
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Volume 14, Issue 3, Pages (September 2008)
MDS Is a Stem Cell Disorder After All
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Development and Migration of Plasma Cells in the Mouse Lymph Node
Volume 45, Issue 2, Pages (August 2016)
Volume 21, Issue 6, Pages (June 2012)
It's ALL in the diagnosis
It's ALL in the diagnosis
Volume 18, Issue 4, Pages (April 2003)
FTY720 Markedly Increases Alloengraftment but Does Not Eliminate Host Anti-Donor T Cells that Cause Graft Rejection on Its Withdrawal  Patricia A. Taylor,
Volume 16, Issue 6, Pages (June 2002)
Volume 7, Issue 6, Pages (December 2010)
The Placenta Is a Niche for Hematopoietic Stem Cells
Volume 20, Issue 2, Pages (August 2011)
Volume 19, Issue 2, Pages (February 2011)
Volume 28, Issue 2, Pages (August 2015)
Volume 2, Issue 4, Pages (April 2008)
Volume 13, Issue 5, Pages (May 2008)
Volume 4, Issue 2, Pages (February 2003)
HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells Ex Vivo
Volume 21, Issue 1, Pages (January 2012)
Volume 42, Issue 6, Pages (June 2015)
Volume 4, Issue 2, Pages (February 2015)
Acquisition of a Functional T Cell Receptor during T Lymphocyte Development Is Enforced by HEB and E2A Transcription Factors  Mary Elizabeth Jones, Yuan.
Clinically Relevant Expansion of Hematopoietic Stem Cells with Conserved Function in a Single-Use, Closed-System Bioprocess  Gerard J. Madlambayan, Ian.
Volume 37, Issue 5, Pages (November 2012)
Hematopoiesis: A Human Perspective
STAT1 acts as a tumor promoter for leukemia development
Volume 43, Issue 2, Pages (August 2015)
Meddling with METTLs in Normal and Leukemia Stem Cells
Volume 12, Issue 4, Pages (April 2013)
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 9, Issue 1, Pages (July 2011)
Volume 10, Issue 2, Pages (February 2018)
Volume 21, Issue 1, Pages (July 2004)
Bmi1 and Cell of Origin Determinants of Brain Tumor Phenotype
Masayuki Yamashita, Eriko Nitta, Toshio Suda  Cell Stem Cell 
Volume 28, Issue 4, Pages (April 2008)
Volume 6, Issue 3, Pages (March 2010)
Volume 17, Issue 4, Pages (October 2002)
Volume 24, Issue 1, Pages (January 2006)
Volume 5, Issue 1, Pages (July 2009)
Volume 29, Issue 4, Pages (October 2008)
Volume 8, Issue 1, Pages (January 2011)
Volume 3, Issue 3, Pages (September 2014)
Common Developmental Pathway for Primitive Erythrocytes and Multipotent Hematopoietic Progenitors in Early Mouse Development  Toshiyuki Yamane, Aya Washino,
Volume 27, Issue 5, Pages (September 2007)
Volume 3, Issue 2, Pages (February 2003)
Volume 7, Issue 5, Pages (November 2010)
Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia by Ross Kinstrie, Dimitris Karamitros, Nicolas Goardon, Heather Morrison,
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
Matthew P. Strout, David G. Schatz  Cancer Cell 
Volume 17, Issue 4, Pages (October 2015)
SLAM Family Markers Resolve Functionally Distinct Subpopulations of Hematopoietic Stem Cells and Multipotent Progenitors  Hideyuki Oguro, Lei Ding, Sean J.
Volume 8, Issue 6, Pages (June 2017)
Volume 2, Issue 3, Pages (March 2008)
Volume 3, Issue 1, Pages (July 2008)
Volume 14, Issue 8, Pages (March 2016)
The Transcriptional Regulation of B Cell Lineage Commitment
Volume 14, Issue 3, Pages (September 2008)
Volume 13, Issue 4, Pages (April 2008)
Presentation transcript:

Volume 14, Issue 1, Pages 47-58 (July 2008) In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties  Christoph le Viseur, Marc Hotfilder, Simon Bomken, Kerrie Wilson, Silja Röttgers, André Schrauder, Annegret Rosemann, Julie Irving, Ronald W. Stam, Leonard D. Shultz, Jochen Harbott, Heribert Jürgens, Martin Schrappe, Rob Pieters, Josef Vormoor  Cancer Cell  Volume 14, Issue 1, Pages 47-58 (July 2008) DOI: 10.1016/j.ccr.2008.05.015 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 The Morphology and Immunophenotype of the Leukemic Blasts Remain Stable for Four Passages in the Mice (A) Original patient #14 blast cell morphology and immunophenotype. (B–E) Bone marrow samples derived from mice serially transplanted with CD34+CD19+ cells from the patient shown in (A). Blast cell morphology and immunophenotype resemble the original patient sample in all four consecutive transplantations. Scale bars = 10 μm. Cancer Cell 2008 14, 47-58DOI: (10.1016/j.ccr.2008.05.015) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 Immunophenotypic Composition of the Leukemic Grafts in the Mice (A) High-risk ALL. The composition of the human grafts in respect to the presence of CD34+CD19− (black), CD34+CD19+ (dark gray), and CD34−CD19+ (light gray) cells resembles that of the original leukemias shown in (C). All three subpopulations were able to reconstitute the complete phenotype of the original leukemia. However, mice transplanted with the more mature CD34−CD19+ immunophenotype engrafted with a slightly lower level of CD34+CD19− cells (0.04% versus 0.2% and 0.3%; p = 0.022) and higher levels of CD34−CD19+ lymphoid cells (36% versus 6.3% and 7.4%; p ≤ 0.001) as compared with mice transplanted with the other two cell fractions. (B) Standard-risk ALL. The composition of the graft was similar in mice that received CD34+CD19+ and CD34−CD19+ cells. Two mice transplanted with CD34+CD19− cells did not engraft. (C) Distribution of the three subpopulations in the original patient samples. Error bars show one SD (not calculated for two standard-risk patients in [C]). Cancer Cell 2008 14, 47-58DOI: (10.1016/j.ccr.2008.05.015) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 All Three Transplanted Subpopulations Can Self-Renew and Serially Transfer the Leukemia in the Mice Each dot plot (except for the patient sample) represents one mouse engrafted with human leukemic cells. Sorting gates and arrows indicate the subpopulation each mouse received from its predecessor. Mouse number and the exact cell dose transplanted into that mouse are provided in the heading of each dot plot. Cancer Cell 2008 14, 47-58DOI: (10.1016/j.ccr.2008.05.015) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 Primary Patient CD34−CD19+ Populations Show Significant Upregulation of the Small Pre-B Cell-Specific Transcription Factor IRF4 Each bar represents pooled quantitative PCR data from four (three for E2A) patient bone marrow specimens taken at diagnosis and sorted into CD34+CD19+ and CD34−CD19+ blast populations. ΔΔCt values between CD34−CD19+ and CD34+CD19+ populations have been transformed and normalized within a patient specimen against the B cell-specific transcription factor PAX5. Expression of IRF4 shows significant upregulation in the more mature CD34−CD19+ population (p < 0.01). Error bars show one SD. Cancer Cell 2008 14, 47-58DOI: (10.1016/j.ccr.2008.05.015) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 Model of the Malleability and Self-Renewal Seen in B Precursor ALL Blasts (A) Normal hematopoiesis. The development from CD34+CD19− early B progenitor expressing transcription factors E2A and EBF1 through to CD34−CD19+CD20+/− small pre-B cells expressing IRF4 and rearranging their immunoglobulin light chain loci. A period of clonal expansion in large pre-B cells is shown. DJH, DH-JH segments rearranged; VH-DJH, rearrangement of the VH-DH segment; VDJH, heavy chain allele rearranged. (B) ALL blast malleability and self-renewal. The blast compartment for high- and low-risk ALL is shown. Within these relatively narrow compartments, blasts are able to upregulate and downregulate components of the normal developmental program, including accessing the self-renewal program at all stages. There is, however, a block to differentiation beyond the B precursor stage. Genes demonstrated as being upregulated are shown below the schema. Cancer Cell 2008 14, 47-58DOI: (10.1016/j.ccr.2008.05.015) Copyright © 2008 Elsevier Inc. Terms and Conditions